DARUNAVIR

DARUNAVIR was reported 15122 times

DARUNAVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 92 0.7132
1 CLOACAL EXSTROPHY 32 0.5424
2 GLUCOCORTICOIDS INCREASED 9 0.4500
3 BLADDER AGENESIS 32 0.4324
4 SUPERNUMERARY NIPPLE 25 0.3049
5 HIV ASSOCIATED NEPHROPATHY 15 0.2941
6 GASTROINTESTINAL DISORDER CONGENITAL 31 0.2925
7 HEMIVERTEBRA 41 0.2426
8 AIDS ENCEPHALOPATHY 14 0.2414
9 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 26 0.2342
10 BLOOD HIV RNA 12 0.2308
11 CONGENITAL NAEVUS 30 0.2113
12 CAUDAL REGRESSION SYNDROME 31 0.1987
13 CONGENITAL ECTOPIC BLADDER 9 0.1875
14 MECONIUM STAIN 28 0.1818
15 ACOUSTIC STIMULATION TESTS ABNORMAL 28 0.1795
16 GENITALIA EXTERNAL AMBIGUOUS 31 0.1792
17 CSF HIV ESCAPE SYNDROME 24 0.1739
18 PERITONEAL CYST 9 0.1667
19 CONGENITAL GENITAL MALFORMATION 26 0.1625
20 SCROTAL CYST 13 0.1529
21 CD4 LYMPHOCYTES ABNORMAL 32 0.1524
22 MITOCHONDRIAL TOXICITY 118 0.1437
23 CONGENITAL INTESTINAL MALFORMATION 16 0.1379
24 TETHERED CORD SYNDROME 30 0.1357
25 ECTOPIC KIDNEY 12 0.1263
26 GASTROINTESTINAL MALFORMATION 25 0.1196
27 CONGENITAL ABSENCE OF BILE DUCTS 8 0.1176
28 CONGENITAL PULMONARY VALVE DISORDER 12 0.1165
29 CONGENITAL MUSCULOSKELETAL DISORDER 10 0.1149
30 LIPODYSTROPHY ACQUIRED 244 0.1148
31 VENTRICULAR HYPOPLASIA 28 0.1120
32 FOETAL GROWTH ABNORMALITY 16 0.1019
33 KARYOTYPE ANALYSIS ABNORMAL 11 0.1009
34 CONGENITAL ANOMALY IN OFFSPRING 13 0.0985
35 TERATOGENICITY 28 0.0927
36 SPINE MALFORMATION 32 0.0922
37 BONE DEMINERALISATION 97 0.0916
38 VIROLOGIC FAILURE 482 0.0895
39 ANOGENITAL DYSPLASIA 13 0.0867
40 PLAGIOCEPHALY 43 0.0862
41 CONGENITAL MITRAL VALVE INCOMPETENCE 11 0.0786
42 LARYNGOMALACIA 26 0.0776
43 FOETAL MALNUTRITION 10 0.0775
44 BLOOD HIV RNA INCREASED 135 0.0744
45 OESOPHAGEAL ATRESIA 46 0.0736
46 LOW SET EARS 30 0.0730
47 CHOLESTASIS OF PREGNANCY 33 0.0717
48 ATRIOVENTRICULAR SEPTAL DEFECT 33 0.0702
49 CD4 LYMPHOCYTES DECREASED 150 0.0700
50 VIRAL MUTATION IDENTIFIED 256 0.0694
51 CONGENITAL CHOROID PLEXUS CYST 21 0.0689
52 NEONATAL RESPIRATORY ARREST 10 0.0685
53 ABORTION OF ECTOPIC PREGNANCY 8 0.0667
54 HIV VIRAEMIA 14 0.0667
55 GENOTYPE DRUG RESISTANCE TEST POSITIVE 68 0.0661
56 UMBILICAL CORD ABNORMALITY 34 0.0645
57 EXOMPHALOS 34 0.0633
58 CONGENITAL HEART VALVE DISORDER 15 0.0630
59 VIRAL LOAD 10 0.0578
60 COLOBOMA 10 0.0535
61 MENINGOMYELOCELE 32 0.0533
62 CONGENITAL HYDRONEPHROSIS 38 0.0531
63 BRAIN STEM STROKE 26 0.0527
64 IMMUNE RECONSTITUTION SYNDROME 68 0.0527
65 ANAL ATRESIA 28 0.0524
66 GENITAL HERPES SIMPLEX 11 0.0519
67 VIRAL LOAD ABNORMAL 9 0.0514
68 SYPHILIS 37 0.0509
69 ACUTE HEPATITIS C 9 0.0492
70 CONGENITAL MULTIPLEX ARTHROGRYPOSIS 10 0.0490
71 CONGENITAL AORTIC ANOMALY 9 0.0481
72 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 16 0.0478
73 ICHTHYOSIS 12 0.0476
74 DYSDIADOCHOKINESIS 8 0.0468
75 POLYDACTYLY 54 0.0466
76 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 232 0.0465
77 CYSTIC LYMPHANGIOMA 8 0.0462
78 GASTROSCHISIS 22 0.0462
79 POST TRANSPLANT DISTAL LIMB SYNDROME 9 0.0443
80 MUSCULOSKELETAL DEFORMITY 10 0.0427
81 ADRENAL SUPPRESSION 36 0.0427
82 CEREBRAL VENTRICLE DILATATION 49 0.0425
83 CHORIOAMNIONITIS 8 0.0421
84 LIPOHYPERTROPHY 26 0.0418
85 FOETAL HEART RATE DISORDER 8 0.0415
86 SUPERIOR MESENTERIC ARTERY SYNDROME 9 0.0404
87 RENAL TUBULAR DYSFUNCTION 22 0.0389
88 URINARY TRACT INFLAMMATION 14 0.0389
89 SKULL MALFORMATION 25 0.0389
90 SUDDEN INFANT DEATH SYNDROME 19 0.0386
91 LEISHMANIASIS 11 0.0379
92 CONGENITAL RENAL DISORDER 10 0.0376
93 ANION GAP ABNORMAL 10 0.0373
94 LEFT VENTRICULAR DILATATION 19 0.0372
95 FANCONI SYNDROME ACQUIRED 65 0.0370
96 LEFT VENTRICULAR ENLARGEMENT 9 0.0353
97 CONDUCTIVE DEAFNESS 11 0.0343
98 TRISOMY 21 43 0.0341
99 FOETAL ARRHYTHMIA 9 0.0335
100 ACQUIRED IMMUNODEFICIENCY SYNDROME 17 0.0328
101 VIRAL LOAD INCREASED 127 0.0327
102 EXTRAOCULAR MUSCLE PARESIS 15 0.0327
103 ANKYLOGLOSSIA CONGENITAL 13 0.0323
104 ENCEPHALOCELE 8 0.0321
105 MICROGNATHIA 16 0.0320
106 PATHOGEN RESISTANCE 291 0.0319
107 HEPATITIS B DNA INCREASED 21 0.0312
108 COMPLICATION OF DELIVERY 9 0.0311
109 CENTRAL OBESITY 22 0.0298
110 PYELOCALIECTASIS 28 0.0292
111 HYPERADRENOCORTICISM 8 0.0291
112 RENAL TUBULAR DISORDER 77 0.0273
113 CENTRAL HYPOTHYROIDISM 9 0.0272
114 CENTRAL NERVOUS SYSTEM INFLAMMATION 9 0.0271
115 ANHEDONIA 705 0.0268
116 SPINA BIFIDA 52 0.0249
117 DYSLIPIDAEMIA 122 0.0240
118 VIRAEMIA 33 0.0238
119 BLOOD CORTISOL DECREASED 15 0.0234
120 NEURAL TUBE DEFECT 17 0.0234
121 AMYOTROPHY 9 0.0233
122 THREATENED LABOUR 10 0.0233
123 CUSHING'S SYNDROME 16 0.0230
124 GENE MUTATION 45 0.0227
125 CONGENITAL MUSCULOSKELETAL ANOMALY 10 0.0227
126 CONGENITAL FOOT MALFORMATION 10 0.0220
127 OPHTHALMOPLEGIA 34 0.0215
128 FOETAL GROWTH RESTRICTION 128 0.0210
129 CONGENITAL DIAPHRAGMATIC HERNIA 8 0.0205
130 PREMATURE RUPTURE OF MEMBRANES 48 0.0199
131 CSF TEST ABNORMAL 10 0.0199
132 FANCONI SYNDROME 28 0.0198
133 CYSTITIS NONINFECTIVE 26 0.0194
134 ECONOMIC PROBLEM 293 0.0193
135 PLEOCYTOSIS 11 0.0189
136 ANAEMIA NEONATAL 9 0.0187
137 STILLBIRTH 89 0.0184
138 LOW BIRTH WEIGHT BABY 142 0.0179
139 GLYCOSURIA 24 0.0178
140 ANENCEPHALY 10 0.0177
141 PREMATURE LABOUR 100 0.0177
142 HIV INFECTION 53 0.0176
143 CUSHINGOID 53 0.0165
144 DRUG RESISTANCE 424 0.0165
145 HELLP SYNDROME 10 0.0163
146 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 17 0.0160
147 HEART DISEASE CONGENITAL 56 0.0158
148 LIVE BIRTH 132 0.0158
149 ANOGENITAL WARTS 14 0.0157
150 SKIN STRIAE 23 0.0154
151 SUPERINFECTION BACTERIAL 12 0.0151
152 AORTIC VALVE SCLEROSIS 11 0.0150
153 OSTEOPENIA 227 0.0149
154 SEPSIS NEONATAL 12 0.0148
155 HYDROPS FOETALIS 9 0.0147
156 MYCOBACTERIUM AVIUM COMPLEX INFECTION 39 0.0145
157 COMPLICATION OF PREGNANCY 11 0.0145
158 FOETAL DEATH 75 0.0144
159 ANAL CANCER 14 0.0144
160 GENITAL HERPES 22 0.0144
161 FOETAL EXPOSURE DURING PREGNANCY 1163 0.0143
162 TOXOPLASMOSIS 15 0.0139
163 CHYLOTHORAX 10 0.0139
164 AMNIOTIC CAVITY INFECTION 10 0.0138
165 LIPIDS ABNORMAL 10 0.0138
166 HIV TEST POSITIVE 9 0.0136
167 CRYSTAL NEPHROPATHY 8 0.0135
168 COARCTATION OF THE AORTA 13 0.0135
169 NEUROPSYCHIATRIC SYMPTOMS 12 0.0133
170 PRURIGO 12 0.0130
171 RENAL COLIC 29 0.0128
172 POLYHYDRAMNIOS 13 0.0127
173 MULTIPLE-DRUG RESISTANCE 39 0.0126
174 HODGKIN'S DISEASE 9 0.0124
175 HEPATITIS CHOLESTATIC 74 0.0123
176 SYNDACTYLY 10 0.0120
177 CONGENITAL CYSTIC KIDNEY DISEASE 10 0.0118
178 CYTOMEGALOVIRUS CHORIORETINITIS 23 0.0118
179 BREAST DISORDER 24 0.0118
180 EYELID PTOSIS 119 0.0117
181 SMALL FOR DATES BABY 57 0.0115
182 ACQUIRED GENE MUTATION 15 0.0114
183 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 10 0.0114
184 LARGE FOR DATES BABY 10 0.0113
185 PREMATURE BABY 340 0.0113
186 DELAYED GRAFT FUNCTION 8 0.0113
187 END STAGE RENAL DISEASE 203 0.0111
188 MENINGITIS CRYPTOCOCCAL 19 0.0109
189 OSTEOPOROSIS 437 0.0106
190 ABORTION INDUCED 100 0.0106
191 HEART TRANSPLANT REJECTION 11 0.0106
192 LIPOATROPHY 10 0.0105
193 DIAPHRAGMATIC DISORDER 8 0.0105
194 MYCOBACTERIAL INFECTION 18 0.0104
195 BONE DENSITY DECREASED 323 0.0103
196 OESOPHAGEAL CANDIDIASIS 41 0.0103
197 GENERALISED ANXIETY DISORDER 15 0.0102
198 COCCIDIOIDOMYCOSIS 12 0.0101
199 PREMATURE DELIVERY 159 0.0100
200 ANAEMIA OF CHRONIC DISEASE 9 0.0100
201 CONGENITAL ANOMALY 77 0.0099
202 HYPERTRIGLYCERIDAEMIA 58 0.0099
203 FOETAL HEART RATE ABNORMAL 9 0.0097
204 VENTRICULAR HYPERTROPHY 24 0.0096
205 WHITE MATTER LESION 12 0.0095
206 PSYCHOMOTOR RETARDATION 26 0.0092
207 EXPOSURE DURING PREGNANCY 571 0.0092
208 GLOMERULAR FILTRATION RATE ABNORMAL 13 0.0092
209 HYDROCEPHALUS 50 0.0092
210 ABORTION SPONTANEOUS 365 0.0091
211 ECTOPIC PREGNANCY 28 0.0091
212 CYTOLYTIC HEPATITIS 30 0.0090
213 PNEUMOCYSTIS JIROVECI PNEUMONIA 20 0.0090
214 PRODUCT PACKAGING ISSUE 84 0.0088
215 SECONDARY ADRENOCORTICAL INSUFFICIENCY 13 0.0086
216 METABOLIC SYNDROME 14 0.0085
217 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 28 0.0085
218 OSTEOMALACIA 13 0.0084
219 MULTIPLE FRACTURES 136 0.0083
220 KIDNEY ENLARGEMENT 9 0.0083
221 HEPATOCELLULAR INJURY 117 0.0082
222 RENAL TUBULAR ACIDOSIS 18 0.0082
223 NEPHROPATHY TOXIC 92 0.0082
224 POSTPARTUM HAEMORRHAGE 11 0.0082
225 PNEUMONIA PNEUMOCOCCAL 12 0.0081
226 ALANINE AMINOTRANSFERASE ABNORMAL 17 0.0081
227 VENTRICULAR SEPTAL DEFECT 46 0.0080
228 MENINGITIS VIRAL 11 0.0080
229 MATERNAL DRUGS AFFECTING FOETUS 61 0.0079
230 LIPIDS INCREASED 16 0.0079
231 NEPHROPATHY 74 0.0079
232 MICROCEPHALY 10 0.0078
233 PREMATURE SEPARATION OF PLACENTA 12 0.0078
234 OLIGOHYDRAMNIOS 26 0.0078
235 CEREBELLAR SYNDROME 17 0.0078
236 FAT TISSUE INCREASED 11 0.0076
237 HYPERPARATHYROIDISM SECONDARY 19 0.0076
238 PRE-ECLAMPSIA 36 0.0076
239 CHRONIC KIDNEY DISEASE 572 0.0075
240 OSTEOPOROTIC FRACTURE 14 0.0073
241 GINGIVAL HYPERTROPHY 11 0.0072
242 DERMATITIS EXFOLIATIVE GENERALISED 25 0.0072
243 BONE LOSS 108 0.0072
244 TALIPES 22 0.0071
245 HYPERTRICHOSIS 13 0.0070
246 HEPATITIS B 42 0.0070
247 OSTEONECROSIS 228 0.0069
248 LABELLED DRUG-DRUG INTERACTION ISSUE 10 0.0069
249 ADRENAL INSUFFICIENCY 83 0.0068
250 EMOTIONAL DISTRESS 813 0.0067
251 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 55 0.0067
252 VITAMIN D DEFICIENCY 65 0.0067
253 MEGACOLON 10 0.0064
254 HYPERPARATHYROIDISM 13 0.0063
255 GESTATIONAL DIABETES 30 0.0063
256 DRUG INTERACTION 992 0.0062
257 DILATATION VENTRICULAR 13 0.0062
258 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 48 0.0062
259 CELL DEATH 12 0.0060
260 MATERNAL EXPOSURE DURING PREGNANCY 538 0.0060
261 DECREASED ACTIVITY 65 0.0060
262 QUALITY OF LIFE DECREASED 80 0.0060
263 PARAINFLUENZAE VIRUS INFECTION 9 0.0059
264 ASPARTATE AMINOTRANSFERASE ABNORMAL 9 0.0059
265 TREATMENT NONCOMPLIANCE 323 0.0059
266 CEREBRAL ISCHAEMIA 30 0.0058
267 DERMATITIS EXFOLIATIVE 29 0.0058
268 SUBSTANCE USE 9 0.0058
269 ATRIAL SEPTAL DEFECT 48 0.0057
270 RENAL TUBULAR NECROSIS 56 0.0057
271 ANAEMIA MACROCYTIC 12 0.0056
272 TOOTH LOSS 112 0.0054
273 HEPATITIS C 65 0.0054
274 RASH MACULO-PAPULAR 119 0.0053
275 BLOOD LACTIC ACID INCREASED 28 0.0053
276 HYPOSPADIAS 11 0.0053
277 HYPERLIPIDAEMIA 63 0.0053
278 PROTEINURIA 100 0.0053
279 BENIGN PROSTATIC HYPERPLASIA 27 0.0052
280 CALCULUS URINARY 8 0.0052
281 BLOOD PHOSPHORUS DECREASED 19 0.0052
282 PSYCHIATRIC DECOMPENSATION 10 0.0051
283 CAESAREAN SECTION 59 0.0051
284 INDURATION 9 0.0050
285 HEPATITIS TOXIC 13 0.0050
286 EOSINOPHILIA 87 0.0050
287 RENAL IMPAIRMENT 409 0.0049
288 INTRAVENTRICULAR HAEMORRHAGE 12 0.0048
289 GASTROINTESTINAL TUBE INSERTION 12 0.0048
290 JAUNDICE NEONATAL 9 0.0048
291 NEPHROGENIC ANAEMIA 22 0.0047
292 HEPATORENAL SYNDROME 8 0.0047
293 SKELETAL INJURY 49 0.0047
294 HEPATITIS B REACTIVATION 15 0.0047
295 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 18 0.0047
296 LYMPHADENOPATHY MEDIASTINAL 9 0.0047
297 PNEUMOCYSTIS JIROVECII PNEUMONIA 47 0.0047
298 HYPERCHOLESTEROLAEMIA 45 0.0047
299 CHOREA 8 0.0046
300 LANGUAGE DISORDER 10 0.0046
301 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0046
302 FOOT FRACTURE 87 0.0046
303 PULSELESS ELECTRICAL ACTIVITY 19 0.0045
304 PORTAL HYPERTENSION 14 0.0045
305 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 40 0.0045
306 DIPLOPIA 117 0.0045
307 CYTOMEGALOVIRUS TEST POSITIVE 8 0.0045
308 CACHEXIA 23 0.0045
309 ABORTION 13 0.0045
310 HYPERURICAEMIA 18 0.0044
311 HYPERBILIRUBINAEMIA 45 0.0043
312 PORTAL VEIN THROMBOSIS 14 0.0043
313 RASH MORBILLIFORM 12 0.0043
314 DEVICE ISSUE 384 0.0043
315 GLOMERULAR FILTRATION RATE DECREASED 52 0.0042
316 FIBROSIS 13 0.0042
317 PULMONARY TUBERCULOSIS 18 0.0042
318 HYPOPHOSPHATAEMIA 31 0.0042
319 CARDIAC MURMUR 36 0.0042
320 SPINAL COMPRESSION FRACTURE 34 0.0041
321 DRUG LEVEL INCREASED 68 0.0041
322 PARADOXICAL DRUG REACTION 15 0.0041
323 GLUCOSE TOLERANCE IMPAIRED 24 0.0041
324 CYTOMEGALOVIRUS COLITIS 9 0.0039
325 OESOPHAGEAL ULCER 15 0.0039
326 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 100 0.0039
327 HEPATITIS ACUTE 25 0.0038
328 CONGESTIVE CARDIOMYOPATHY 16 0.0038
329 PROTEIN URINE PRESENT 19 0.0038
330 HAND FRACTURE 27 0.0038
331 BLOOD CREATININE INCREASED 248 0.0038
332 RETINOPATHY 14 0.0037
333 RENAL FAILURE 498 0.0037
334 RADIUS FRACTURE 9 0.0037
335 BRONCHITIS CHRONIC 9 0.0037
336 DRUG EXPOSURE DURING PREGNANCY 125 0.0037
337 CERVICAL DYSPLASIA 8 0.0037
338 EXERCISE TOLERANCE DECREASED 21 0.0036
339 ORAL CANDIDIASIS 48 0.0036
340 COMPLICATIONS OF TRANSPLANTED KIDNEY 8 0.0035
341 ENCEPHALITIS 24 0.0035
342 AORTIC STENOSIS 12 0.0034
343 TREATMENT FAILURE 285 0.0034
344 DRUG LEVEL DECREASED 35 0.0034
345 TIBIA FRACTURE 16 0.0034
346 DYSMORPHISM 8 0.0034
347 CHOLESTASIS 65 0.0034
348 PROTEIN TOTAL INCREASED 9 0.0034
349 NEUTROPENIC SEPSIS 24 0.0034
350 RENAL TRANSPLANT 12 0.0033
351 RENAL FAILURE ACUTE 140 0.0033
352 BLOOD TRIGLYCERIDES INCREASED 58 0.0033
353 HYPERPHAGIA 13 0.0033
354 ANGINA UNSTABLE 21 0.0032
355 ACUTE KIDNEY INJURY 493 0.0032
356 IMMUNE THROMBOCYTOPENIC PURPURA 9 0.0032
357 ODYNOPHAGIA 19 0.0032
358 GOITRE 13 0.0032
359 EUGLYCAEMIC DIABETIC KETOACIDOSIS 13 0.0031
360 CLOSTRIDIUM DIFFICILE COLITIS 33 0.0031
361 ESCHERICHIA SEPSIS 9 0.0031
362 BUNDLE BRANCH BLOCK RIGHT 14 0.0030
363 POLYDIPSIA 12 0.0030
364 RENAL INJURY 89 0.0030
365 INTRACRANIAL ANEURYSM 12 0.0030
366 HYPERLACTACIDAEMIA 8 0.0030
367 AMYLASE INCREASED 11 0.0030
368 NEUROLOGICAL SYMPTOM 17 0.0030
369 BLOOD BILIRUBIN INCREASED 80 0.0030
370 TUMOUR LYSIS SYNDROME 26 0.0030
371 BLOOD CREATINE PHOSPHOKINASE INCREASED 85 0.0029
372 HUMERUS FRACTURE 14 0.0029
373 NEPHROLITHIASIS 133 0.0029
374 ENTEROCOCCAL INFECTION 14 0.0029
375 TOXIC SKIN ERUPTION 29 0.0029
376 AUTOIMMUNE HEPATITIS 20 0.0029
377 LIVER FUNCTION TEST ABNORMAL 83 0.0029
378 ANXIETY 812 0.0029
379 IRIDOCYCLITIS 9 0.0028
380 FEBRILE BONE MARROW APLASIA 12 0.0028
381 HEPATIC CYTOLYSIS 36 0.0028
382 ACUTE MYOCARDIAL INFARCTION 83 0.0028
383 PRODUCT SIZE ISSUE 15 0.0028
384 HEPATOTOXICITY 62 0.0028
385 ACUTE CORONARY SYNDROME 23 0.0028
386 BEHAVIOUR DISORDER 15 0.0028
387 PATENT DUCTUS ARTERIOSUS 11 0.0028
388 TOOTH INJURY 12 0.0028
389 BLOOD IRON DECREASED 32 0.0027
390 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 128 0.0027
391 RHABDOMYOLYSIS 111 0.0027
392 RIB FRACTURE 54 0.0026
393 FACE OEDEMA 44 0.0026
394 HEPATIC PAIN 11 0.0026
395 TOOTH FRACTURE 28 0.0025
396 HYDRONEPHROSIS 19 0.0025
397 PANCREATITIS ACUTE 57 0.0025
398 MONOPLEGIA 11 0.0025
399 EMBOLISM 21 0.0025
400 JAUNDICE 68 0.0025
401 PRODUCT LABEL ISSUE 17 0.0025
402 SUBCUTANEOUS ABSCESS 12 0.0025
403 WRIST FRACTURE 30 0.0025
404 MALABSORPTION 13 0.0025
405 PANCYTOPENIA 139 0.0025
406 AGRANULOCYTOSIS 46 0.0025
407 MAJOR DEPRESSION 18 0.0025
408 RENAL PAIN 26 0.0025
409 NYSTAGMUS 13 0.0024
410 MYOPATHY 21 0.0024
411 VENTRICULAR FIBRILLATION 27 0.0024
412 TRANSAMINASES INCREASED 54 0.0024
413 BONE DENSITY ABNORMAL 9 0.0024
414 PERIPHERAL SENSORY NEUROPATHY 14 0.0024
415 NORMAL NEWBORN 13 0.0024
416 HEPATIC NECROSIS 9 0.0024
417 OCULAR ICTERUS 10 0.0023
418 STATUS EPILEPTICUS 26 0.0023
419 HEPATIC FAILURE 69 0.0023
420 CYTOMEGALOVIRUS INFECTION 38 0.0023
421 HYPOTHERMIA 23 0.0023
422 HAEMORRHAGIC DIATHESIS 8 0.0022
423 ILEUS PARALYTIC 10 0.0022
424 HEPATOMEGALY 22 0.0022
425 POST-TRAUMATIC STRESS DISORDER 15 0.0022
426 EYELID OEDEMA 26 0.0022
427 ANAL ABSCESS 12 0.0022
428 PERIPHERAL VENOUS DISEASE 9 0.0022
429 LOW DENSITY LIPOPROTEIN INCREASED 17 0.0022
430 BRAIN INJURY 22 0.0022
431 LYMPHOPENIA 31 0.0022
432 TUBULOINTERSTITIAL NEPHRITIS 41 0.0022
433 LYMPHOEDEMA 15 0.0022
434 ANKLE FRACTURE 33 0.0021
435 GAMMA-GLUTAMYLTRANSFERASE INCREASED 47 0.0021
436 HAEMOLYTIC ANAEMIA 19 0.0021
437 MYOSITIS 19 0.0021
438 STEVENS-JOHNSON SYNDROME 47 0.0021
439 HEPATITIS 54 0.0021
440 DRUG-INDUCED LIVER INJURY 66 0.0021
441 RASH GENERALISED 54 0.0021
442 SOCIAL AVOIDANT BEHAVIOUR 12 0.0021
443 ENTERITIS 13 0.0020
444 PANCREATIC DISORDER 10 0.0020
445 CANDIDA INFECTION 34 0.0020
446 HAEMARTHROSIS 18 0.0020
447 LACTIC ACIDOSIS 65 0.0020
448 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
449 SPINAL FRACTURE 40 0.0020
450 PAPILLOEDEMA 9 0.0020
451 ALANINE AMINOTRANSFERASE INCREASED 122 0.0020
452 CORONARY ARTERY DISEASE 60 0.0020
453 ASCITES 58 0.0020
454 HEPATIC CIRRHOSIS 37 0.0020
455 ANAEMIA 373 0.0020
456 DIFFUSE LARGE B-CELL LYMPHOMA 15 0.0019
457 LYMPHOMA 30 0.0019
458 ASPARTATE AMINOTRANSFERASE INCREASED 103 0.0019
459 GENERALISED ERYTHEMA 11 0.0019
460 DERMATITIS BULLOUS 14 0.0019
461 ARTERIOSCLEROSIS 18 0.0019
462 MULTI-ORGAN FAILURE 33 0.0019
463 BLOOD PROLACTIN INCREASED 9 0.0019
464 DEPRESSION 434 0.0019
465 CARDIAC TAMPONADE 9 0.0019
466 MEDICATION RESIDUE PRESENT 9 0.0019
467 INCORRECT PRODUCT STORAGE 24 0.0018
468 NEUROTOXICITY 32 0.0018
469 BLOOD CREATINE INCREASED 8 0.0018
470 MENINGITIS 12 0.0018
471 PULMONARY HYPERTENSION 37 0.0018
472 SEROTONIN SYNDROME 34 0.0018
473 EPSTEIN-BARR VIRUS INFECTION 11 0.0018
474 HYPERGLYCAEMIA 64 0.0018
475 ACUTE HEPATIC FAILURE 24 0.0018
476 INFARCTION 12 0.0018
477 CENTRAL NERVOUS SYSTEM LESION 24 0.0017
478 HYPERTONIA 10 0.0017
479 ANURIA 15 0.0017
480 CORONARY ARTERY BYPASS 10 0.0017
481 RENAL DISORDER 81 0.0017
482 FAILURE TO THRIVE 9 0.0017
483 NERVOUS SYSTEM DISORDER 54 0.0017
484 HEPATIC STEATOSIS 32 0.0017
485 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
486 HYPOVOLAEMIA 10 0.0017
487 ACIDOSIS 13 0.0017
488 MALNUTRITION 19 0.0017
489 PREGNANCY 34 0.0017
490 PURPURA 15 0.0017
491 FRACTURE 32 0.0017
492 THROMBOCYTOPENIA 189 0.0017
493 BRAIN OEDEMA 21 0.0017
494 BLOOD ALKALINE PHOSPHATASE INCREASED 41 0.0016
495 PANCREATITIS 87 0.0016
496 ELECTROCARDIOGRAM QT PROLONGED 59 0.0016
497 RENAL CYST 13 0.0016
498 PYELONEPHRITIS 14 0.0016
499 HEPATIC ENCEPHALOPATHY 15 0.0016
500 SQUAMOUS CELL CARCINOMA 15 0.0016
501 ERYSIPELAS 8 0.0016
502 HYPERTHYROIDISM 23 0.0016
503 ACUTE RESPIRATORY DISTRESS SYNDROME 28 0.0016
504 DYSSTASIA 46 0.0016
505 HERPES VIRUS INFECTION 9 0.0016
506 LIVER INJURY 38 0.0015
507 POOR QUALITY DRUG ADMINISTERED 10 0.0015
508 HYPOALBUMINAEMIA 12 0.0015
509 WRONG TECHNIQUE IN DRUG USAGE PROCESS 56 0.0015
510 HERPES SIMPLEX 10 0.0015
511 BONE DISORDER 28 0.0015
512 GENERALISED OEDEMA 19 0.0015
513 DRUG ERUPTION 27 0.0015
514 ATAXIA 18 0.0015
515 RASH PUSTULAR 11 0.0015
516 ENCEPHALOPATHY 37 0.0015
517 HIP ARTHROPLASTY 23 0.0015
518 ORAL DISORDER 11 0.0015
519 CHEILITIS 8 0.0015
520 METABOLIC ACIDOSIS 47 0.0015
521 LIVER DISORDER 65 0.0015
522 MATERNAL EXPOSURE BEFORE PREGNANCY 10 0.0015
523 PAIN 891 0.0014
524 MULTIPLE ORGAN DYSFUNCTION SYNDROME 41 0.0014
525 GASTROENTERITIS 21 0.0014
526 POLLAKIURIA 60 0.0014
527 LIPASE INCREASED 11 0.0014
528 MENTAL DISORDER 62 0.0014
529 DIABETES MELLITUS 108 0.0014
530 LYMPHADENOPATHY 50 0.0014
531 FACIAL PARALYSIS 12 0.0014
532 EPILEPSY 43 0.0014
533 HYPERKALAEMIA 49 0.0014
534 SHOCK 32 0.0014
535 MUSCLE STRAIN 12 0.0014
536 TRANSPLANT REJECTION 11 0.0014
537 NIGHTMARE 47 0.0014
538 NEUROPATHY PERIPHERAL 129 0.0014
539 PSYCHIATRIC SYMPTOM 10 0.0014
540 LOWER LIMB FRACTURE 26 0.0014
541 PARKINSONISM 13 0.0013
542 PRODUCT USE COMPLAINT 21 0.0013
543 GENERAL PHYSICAL CONDITION ABNORMAL 9 0.0013
544 HYPOKALAEMIA 61 0.0013
545 HEPATIC FUNCTION ABNORMAL 49 0.0013
546 NEPHROTIC SYNDROME 9 0.0013
547 HYPERTHERMIA 10 0.0013
548 PNEUMONIA BACTERIAL 12 0.0013
549 OSTEOARTHRITIS 55 0.0013
550 PHARYNGITIS 16 0.0013
551 BIPOLAR DISORDER 14 0.0013
552 CARPAL TUNNEL SYNDROME 18 0.0013
553 APNOEA 10 0.0013
554 SKIN HYPERPIGMENTATION 11 0.0013
555 PARANOIA 22 0.0013
556 NERVE INJURY 14 0.0013
557 HAEMATURIA 43 0.0013
558 POLYNEUROPATHY 15 0.0013
559 DRUG DISPENSING ERROR 19 0.0012
560 NOCTURIA 15 0.0012
561 MYOCARDITIS 14 0.0012
562 POLYURIA 10 0.0012
563 VITREOUS FLOATERS 12 0.0012
564 ASPERGILLUS INFECTION 8 0.0012
565 HICCUPS 10 0.0012
566 CORONAVIRUS INFECTION 8 0.0012
567 IMMUNODEFICIENCY 18 0.0012
568 ERECTILE DYSFUNCTION 31 0.0012
569 SYRINGE ISSUE 21 0.0012
570 DIALYSIS 17 0.0012
571 RESPIRATORY DISTRESS 33 0.0012
572 SPLENOMEGALY 14 0.0012
573 HAEMODIALYSIS 10 0.0012
574 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
575 TENDON PAIN 9 0.0012
576 HEPATOCELLULAR CARCINOMA 9 0.0012
577 ERYTHEMA MULTIFORME 11 0.0012
578 RENAL FAILURE CHRONIC 9 0.0012
579 PSEUDOMONAS INFECTION 10 0.0012
580 HIP FRACTURE 37 0.0011
581 FOLLICULITIS 12 0.0011
582 DYSPHAGIA 108 0.0011
583 IMMUNOSUPPRESSION 10 0.0011
584 TYPE 2 DIABETES MELLITUS 38 0.0011
585 C-REACTIVE PROTEIN INCREASED 41 0.0011
586 IMPAIRED WORK ABILITY 24 0.0011
587 RHINITIS 9 0.0011
588 GENERAL PHYSICAL HEALTH DETERIORATION 128 0.0011
589 UVEITIS 15 0.0011
590 FAECES SOFT 8 0.0011
591 TOXICITY TO VARIOUS AGENTS 183 0.0011
592 HYPONATRAEMIA 61 0.0011
593 EOSINOPHIL COUNT INCREASED 9 0.0011
594 NEUTROPENIA 144 0.0011
595 MOBILITY DECREASED 76 0.0011
596 SKIN LESION 29 0.0011
597 SKIN ULCER 27 0.0010
598 HEPATIC ENZYME INCREASED 71 0.0010
599 ELECTROLYTE IMBALANCE 12 0.0010
600 MUSCLE ATROPHY 13 0.0010
601 HAEMORRHAGIC STROKE 8 0.0010
602 SEPSIS 114 0.0010
603 DECREASED IMMUNE RESPONSIVENESS 10 0.0010
604 CARDIAC ARREST 84 0.0010
605 COVID-19 PNEUMONIA 12 0.0010
606 RESPIRATORY RATE INCREASED 9 0.0010
607 DRUG SCREEN POSITIVE 8 0.0010
608 BACTERAEMIA 12 0.0010
609 BLOOD LACTATE DEHYDROGENASE INCREASED 16 0.0010
610 BLOOD CHOLESTEROL INCREASED 47 0.0010
611 MYOCLONUS 12 0.0010
612 GOUT 18 0.0010
613 GASTRIC ULCER 19 0.0010
614 THROMBOSIS 80 0.0010
615 EMPHYSEMA 10 0.0010
616 SEPTIC SHOCK 43 0.0010
617 MUSCULOSKELETAL DISCOMFORT 17 0.0010
618 PSYCHOTIC DISORDER 29 0.0010
619 DEVICE RELATED INFECTION 15 0.0010
620 MYOCARDIAL INFARCTION 169 0.0010
621 PYREXIA 335 0.0010
622 MYOCARDIAL ISCHAEMIA 11 0.0010
623 ADVERSE EVENT 89 0.0010
624 OEDEMA 52 0.0010
625 HEPATIC CANCER 23 0.0010
626 UPPER LIMB FRACTURE 19 0.0010
627 ANGIOEDEMA 42 0.0009
628 POISONING DELIBERATE 9 0.0009
629 SUDDEN DEATH 10 0.0009
630 POST PROCEDURAL HAEMORRHAGE 11 0.0009
631 OBESITY 15 0.0009
632 RASH PRURITIC 51 0.0009
633 MYDRIASIS 12 0.0009
634 HYPERTENSION 198 0.0009
635 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
636 PRESCRIBED OVERDOSE 18 0.0009
637 DIZZINESS POSTURAL 9 0.0009
638 DYSURIA 34 0.0009
639 MUCOSAL INFLAMMATION 24 0.0009
640 SINUS TACHYCARDIA 13 0.0009
641 OESOPHAGITIS 10 0.0009
642 NEURALGIA 22 0.0009
643 DENTAL CARIES 10 0.0009
644 CEREBRAL INFARCTION 22 0.0009
645 ISCHAEMIC STROKE 16 0.0009
646 BLOOD URINE PRESENT 17 0.0009
647 HYPERCALCAEMIA 11 0.0009
648 FEBRILE NEUTROPENIA 59 0.0009
649 DRUG PRESCRIBING ERROR 17 0.0009
650 HALLUCINATION, AUDITORY 14 0.0009
651 GASTROINTESTINAL CARCINOMA 8 0.0009
652 SUICIDAL IDEATION 80 0.0009
653 GAIT DISTURBANCE 167 0.0009
654 HOSPITALISATION 134 0.0009
655 MYALGIA 148 0.0009
656 DELIRIUM 30 0.0009
657 RESPIRATORY FAILURE 63 0.0009
658 CONJUNCTIVITIS 16 0.0009
659 SUBDURAL HAEMATOMA 12 0.0008
660 BONE MARROW FAILURE 17 0.0008
661 IMMUNE SYSTEM DISORDER 11 0.0008
662 ABNORMAL DREAMS 23 0.0008
663 PRURITUS GENERALISED 18 0.0008
664 RASH 362 0.0008
665 PANIC ATTACK 30 0.0008
666 NO THERAPEUTIC RESPONSE 10 0.0008
667 DRUG INTOLERANCE 79 0.0008
668 LABORATORY TEST ABNORMAL 24 0.0008
669 FEMUR FRACTURE 25 0.0008
670 AGITATION 59 0.0008
671 CORONARY ARTERY OCCLUSION 11 0.0008
672 MITRAL VALVE INCOMPETENCE 9 0.0008
673 DERMATITIS ALLERGIC 10 0.0008
674 WEIGHT INCREASED 178 0.0008
675 MENTAL STATUS CHANGES 22 0.0008
676 MENTAL IMPAIRMENT 19 0.0008
677 HYPOPHAGIA 20 0.0008
678 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
679 COAGULOPATHY 13 0.0008
680 ANOREXIA 10 0.0008
681 DIARRHOEA 500 0.0008
682 LUNG INFECTION 12 0.0008
683 HIATUS HERNIA 10 0.0008
684 VERTIGO 47 0.0008
685 DYSARTHRIA 29 0.0008
686 LOWER RESPIRATORY TRACT INFECTION 35 0.0008
687 BASAL CELL CARCINOMA 12 0.0008
688 RESTLESSNESS 28 0.0008
689 HYPOKINESIA 11 0.0008
690 DEPRESSED MOOD 40 0.0008
691 CEREBRAL HAEMORRHAGE 27 0.0008
692 ACCIDENT 9 0.0008
693 SLEEP DISORDER 53 0.0008
694 DRUG ADMINISTRATION ERROR 23 0.0007
695 FEAR 20 0.0007
696 SCHIZOPHRENIA 9 0.0007
697 COLON CANCER 11 0.0007
698 TACHYPNOEA 10 0.0007
699 DRUG TOXICITY 10 0.0007
700 HAEMATOMA 19 0.0007
701 ACUTE RESPIRATORY FAILURE 14 0.0007
702 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
703 AMNESIA 47 0.0007
704 HYPOTHYROIDISM 23 0.0007
705 LEUKOPENIA 36 0.0007
706 SEIZURE 83 0.0007
707 CEREBROVASCULAR ACCIDENT 121 0.0007
708 TENDONITIS 11 0.0007
709 CHROMATURIA 16 0.0007
710 COGNITIVE DISORDER 33 0.0007
711 ABDOMINAL PAIN 163 0.0007
712 BONE PAIN 41 0.0007
713 ASTHENIA 261 0.0007
714 CARDIO-RESPIRATORY ARREST 29 0.0007
715 SWELLING FACE 45 0.0007
716 RESPIRATORY TRACT INFECTION 18 0.0007
717 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
718 COLITIS 26 0.0007
719 INSOMNIA 182 0.0007
720 DEHYDRATION 91 0.0007
721 PNEUMONIA ASPIRATION 17 0.0007
722 WEIGHT DECREASED 188 0.0007
723 CHOLECYSTITIS 8 0.0007
724 CHOLELITHIASIS 22 0.0007
725 CONFUSIONAL STATE 108 0.0007
726 HAEMORRHOIDS 13 0.0007
727 ANGINA PECTORIS 19 0.0007
728 KIDNEY INFECTION 13 0.0007
729 VISUAL ACUITY REDUCED 22 0.0007
730 BLOOD UREA INCREASED 11 0.0007
731 ADVERSE DRUG REACTION 59 0.0007
732 ABDOMINAL DISTENSION 68 0.0007
733 COMA 31 0.0007
734 MASS 9 0.0006
735 PRODUCT DOSE OMISSION 42 0.0006
736 SUICIDE ATTEMPT 39 0.0006
737 BRADYCARDIA 34 0.0006
738 DYSPNOEA EXERTIONAL 24 0.0006
739 DRUG DOSE OMISSION 105 0.0006
740 MUSCULAR WEAKNESS 72 0.0006
741 ORTHOSTATIC HYPOTENSION 11 0.0006
742 TINNITUS 29 0.0006
743 DISORIENTATION 25 0.0006
744 MUSCULOSKELETAL DISORDER 12 0.0006
745 APHASIA 19 0.0006
746 VOMITING 295 0.0006
747 GASTROINTESTINAL DISORDER 56 0.0006
748 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
749 PULMONARY EMBOLISM 59 0.0006
750 APATHY 9 0.0006
751 THIRST 11 0.0006
752 BEDRIDDEN 8 0.0006
753 EYE DISORDER 20 0.0006
754 VENTRICULAR TACHYCARDIA 10 0.0006
755 BACK PAIN 140 0.0006
756 SKIN DISORDER 20 0.0006
757 HYPOAESTHESIA ORAL 9 0.0006
758 TACHYCARDIA 53 0.0006
759 PRODUCT PHYSICAL ISSUE 12 0.0006
760 CARDIOVASCULAR DISORDER 15 0.0006
761 DYSPEPSIA 58 0.0006
762 PRODUCT PRESCRIBING ERROR 14 0.0006
763 PNEUMONIA 190 0.0006
764 PHOTOPHOBIA 11 0.0006
765 GASTRIC DISORDER 20 0.0006
766 DEATH 500 0.0006
767 RASH PAPULAR 13 0.0006
768 PERITONITIS 12 0.0006
769 LOCAL SWELLING 10 0.0006
770 CONDITION AGGRAVATED 174 0.0006
771 GASTRITIS 15 0.0006
772 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
773 MOVEMENT DISORDER 18 0.0006
774 SYNCOPE 56 0.0006
775 NIGHT SWEATS 18 0.0006
776 OVERDOSE 120 0.0006
777 BLOOD POTASSIUM INCREASED 9 0.0006
778 HYPOTENSION 111 0.0006
779 OSTEOMYELITIS 10 0.0006
780 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
781 STAPHYLOCOCCAL INFECTION 18 0.0005
782 INTENTIONAL OVERDOSE 35 0.0005
783 SKIN DISCOLOURATION 25 0.0005
784 RASH ERYTHEMATOUS 26 0.0005
785 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
786 CONVULSION 31 0.0005
787 LIP SWELLING 18 0.0005
788 MEDICATION ERROR 30 0.0005
789 PERICARDITIS 9 0.0005
790 DEAFNESS 14 0.0005
791 HYPERSENSITIVITY 99 0.0005
792 HEMIPARESIS 9 0.0005
793 DEEP VEIN THROMBOSIS 34 0.0005
794 PARAESTHESIA 82 0.0005
795 DEVICE DEFECTIVE 9 0.0005
796 FATIGUE 404 0.0005
797 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
798 NAUSEA 406 0.0005
799 BLOOD PRESSURE DECREASED 34 0.0005
800 HYPOXIA 18 0.0005
801 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
802 INFECTION 73 0.0005
803 ASTHMA 57 0.0005
804 COMPLETED SUICIDE 42 0.0005
805 OEDEMA PERIPHERAL 61 0.0005
806 ERYTHEMA 102 0.0005
807 ACCIDENTAL OVERDOSE 18 0.0005
808 RASH MACULAR 17 0.0005
809 ARRHYTHMIA 23 0.0005
810 CARDIAC FAILURE CONGESTIVE 39 0.0005
811 BACTERIAL INFECTION 9 0.0005
812 BLISTER 27 0.0005
813 URINARY RETENTION 16 0.0005
814 BLOOD SODIUM DECREASED 9 0.0005
815 CELLULITIS 24 0.0005
816 HYPOCALCAEMIA 9 0.0005
817 CHEST PAIN 88 0.0005
818 ANGER 16 0.0005
819 HERPES ZOSTER 27 0.0005
820 EATING DISORDER 10 0.0005
821 OFF LABEL USE 408 0.0005
822 NEOPLASM MALIGNANT 31 0.0005
823 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
824 PALPITATIONS 54 0.0005
825 MENORRHAGIA 9 0.0005
826 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
827 URINARY TRACT INFECTION 78 0.0005
828 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
829 HYPOGLYCAEMIA 22 0.0005
830 NO ADVERSE EVENT 82 0.0005
831 LETHARGY 26 0.0005
832 SKIN EXFOLIATION 38 0.0004
833 HYPERHIDROSIS 58 0.0004
834 GASTROOESOPHAGEAL REFLUX DISEASE 36 0.0004
835 ARTHRITIS 35 0.0004
836 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
837 OROPHARYNGEAL PAIN 41 0.0004
838 MALAISE 191 0.0004
839 RESPIRATORY ARREST 12 0.0004
840 HAEMATEMESIS 11 0.0004
841 ARTHRALGIA 178 0.0004
842 PRURITUS 164 0.0004
843 DISTURBANCE IN ATTENTION 23 0.0004
844 NERVOUSNESS 22 0.0004
845 DISEASE RECURRENCE 20 0.0004
846 RECTAL HAEMORRHAGE 18 0.0004
847 GAIT INABILITY 14 0.0004
848 BRONCHITIS 31 0.0004
849 HAEMOGLOBIN DECREASED 43 0.0004
850 FAECES DISCOLOURED 9 0.0004
851 EAR PAIN 8 0.0004
852 HEADACHE 255 0.0004
853 TOOTH DISORDER 9 0.0004
854 DISABILITY 8 0.0004
855 MOOD ALTERED 11 0.0004
856 SPEECH DISORDER 21 0.0004
857 PRODUCT USE IN UNAPPROVED INDICATION 99 0.0004
858 INJURY 28 0.0004
859 HEART RATE IRREGULAR 9 0.0004
860 PLEURAL EFFUSION 24 0.0004
861 HYPOAESTHESIA 59 0.0004
862 DEVICE BREAKAGE 16 0.0004
863 INJECTION SITE REACTION 27 0.0004
864 INFLAMMATION 20 0.0004
865 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
866 PROSTATE CANCER 31 0.0004
867 HAEMORRHAGE 40 0.0004
868 DRY MOUTH 31 0.0004
869 DERMATITIS 8 0.0004
870 PULMONARY OEDEMA 17 0.0004
871 INTENTIONAL PRODUCT MISUSE 33 0.0004
872 INFLUENZA 42 0.0004
873 CHILLS 44 0.0004
874 NEOPLASM PROGRESSION 13 0.0004
875 PAIN IN EXTREMITY 110 0.0004
876 DECREASED APPETITE 86 0.0004
877 THERAPY CESSATION 19 0.0004
878 NEUTROPHIL COUNT DECREASED 15 0.0004
879 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
880 RESPIRATORY DISORDER 11 0.0004
881 COUGH 102 0.0004
882 CARDIAC FAILURE 29 0.0004
883 FUNGAL INFECTION 12 0.0004
884 SOMNOLENCE 72 0.0004
885 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
886 THERAPY NON-RESPONDER 16 0.0004
887 ABDOMINAL PAIN LOWER 9 0.0004
888 ABDOMINAL DISCOMFORT 59 0.0004
889 IRRITABILITY 21 0.0003
890 ANAPHYLACTIC SHOCK 9 0.0003
891 HALLUCINATION 26 0.0003
892 ABDOMINAL PAIN UPPER 71 0.0003
893 MUSCULOSKELETAL PAIN 18 0.0003
894 LUNG NEOPLASM MALIGNANT 14 0.0003
895 NECK PAIN 19 0.0003
896 DYSPNOEA 191 0.0003
897 PRODUCTIVE COUGH 16 0.0003
898 GASTROINTESTINAL HAEMORRHAGE 28 0.0003
899 DRUG INEFFECTIVE 440 0.0003
900 THROAT TIGHTNESS 9 0.0003
901 TREMOR 55 0.0003
902 LIMB INJURY 9 0.0003
903 CRYING 12 0.0003
904 THERAPEUTIC RESPONSE DECREASED 20 0.0003
905 PLATELET COUNT DECREASED 35 0.0003
906 FALL 109 0.0003
907 FEELING HOT 20 0.0003
908 INJECTION SITE MASS 12 0.0003
909 CARDIAC DISORDER 30 0.0003
910 FLATULENCE 18 0.0003
911 HYPERSOMNIA 9 0.0003
912 DRUG ABUSE 26 0.0003
913 SWELLING 29 0.0003
914 COVID-19 54 0.0003
915 DIZZINESS 152 0.0003
916 URTICARIA 51 0.0003
917 VIRAL INFECTION 10 0.0003
918 AGGRESSION 15 0.0003
919 VISUAL IMPAIRMENT 37 0.0003
920 MEMORY IMPAIRMENT 41 0.0003
921 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
922 EXTRA DOSE ADMINISTERED 12 0.0003
923 FLUID RETENTION 15 0.0003
924 BLINDNESS 12 0.0003
925 CHEST DISCOMFORT 30 0.0003
926 CONTUSION 28 0.0003
927 UNEVALUABLE EVENT 22 0.0003
928 INTERSTITIAL LUNG DISEASE 14 0.0003
929 PRODUCT USE ISSUE 54 0.0003
930 HAEMOPTYSIS 8 0.0003
931 LUNG DISORDER 14 0.0003
932 EYE PAIN 16 0.0003
933 DYSGEUSIA 21 0.0003
934 MUSCLE SPASMS 51 0.0003
935 ABNORMAL BEHAVIOUR 11 0.0003
936 LOSS OF CONSCIOUSNESS 35 0.0003
937 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
938 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
939 BALANCE DISORDER 23 0.0003
940 DISCOMFORT 16 0.0003
941 BLOOD GLUCOSE INCREASED 49 0.0003
942 PERIPHERAL SWELLING 40 0.0003
943 GYNAECOMASTIA 8 0.0003
944 BURNING SENSATION 18 0.0003
945 SURGERY 15 0.0003
946 EPISTAXIS 19 0.0003
947 DYSKINESIA 10 0.0002
948 PRODUCT QUALITY ISSUE 33 0.0002
949 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
950 VISION BLURRED 32 0.0002
951 STOMATITIS 14 0.0002
952 HEART RATE DECREASED 8 0.0002
953 THROAT IRRITATION 10 0.0002
954 PRODUCT STORAGE ERROR 19 0.0002
955 MUSCULOSKELETAL STIFFNESS 19 0.0002
956 INCORRECT DOSE ADMINISTERED 48 0.0002
957 PRODUCT SUBSTITUTION ISSUE 12 0.0002
958 FLUSHING 21 0.0002
959 INFLUENZA LIKE ILLNESS 17 0.0002
960 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
961 DISEASE PROGRESSION 24 0.0002
962 CONSTIPATION 44 0.0002
963 MIGRAINE 19 0.0002
964 ARTHROPATHY 11 0.0002
965 OXYGEN SATURATION DECREASED 11 0.0002
966 MALIGNANT NEOPLASM PROGRESSION 20 0.0002
967 ATRIAL FIBRILLATION 19 0.0002
968 NASAL CONGESTION 11 0.0002
969 CATARACT 11 0.0002
970 ACNE 14 0.0002
971 SINUSITIS 18 0.0002
972 ALOPECIA 34 0.0002
973 FEELING ABNORMAL 41 0.0002
974 JOINT SWELLING 20 0.0002
975 UNDERDOSE 12 0.0002
976 DRUG WITHDRAWAL SYNDROME 14 0.0002
977 RHINORRHOEA 10 0.0002
978 NASOPHARYNGITIS 28 0.0002
979 BLOOD PRESSURE INCREASED 23 0.0002
980 DRY SKIN 20 0.0001
981 ILL-DEFINED DISORDER 9 0.0001
982 HOT FLUSH 11 0.0001
983 ILLNESS 12 0.0001
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 23 0.0001
985 PRODUCT DOSE OMISSION ISSUE 33 0.0001
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
987 HEART RATE INCREASED 8 0.0001
988 DRUG DEPENDENCE 12 0.0001
989 INJECTION SITE PAIN 12 0.0000